Phenolic content and antioxidant activity of ASE
The phytochemical analysis showed that ASE contains some amounts of phenolic compounds (0.717 ± 0.102 mg gallic acid eq/g ASE) and has no flavonoids. Certain types of these phenolic compounds were identified by HPLC (Fig. 1A) such as gallic acid (0.1 µg/g ASE), ellagic acid (1.6 µg/g ASE), benzoic acid (0.3 µg/g ASE), and O-coumaric acid (0.1 µg/g ASE). however, the retention times (RT) of the other tested standard phenolics (catechol, caffeine, vanillin, vanillic acid, caffeic acid, syringic acid, p-coumaric acid, cinnamic acid, and salicylic acid) didn’t match any RT in the ASE chromatogram.
Regarding the antioxidant activity of ASE (Fig. 1B), it exhibited potent anti-lipid peroxidation activity (β-carotene bleaching activity) that was significantly (p < 0.05) higher than that of butylated hydroxytoluene (BHT) by 73.754%. In addition, it showed high scavenging ability to the ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) cation radical and NO radical, but less than that of BHT by 1187.058% and 714.527%, respectively.
The ameliorating effect of ASE on CCl4-induced systemic toxicity
The results of the present study demonstrated that ASE was able to ameliorate the CCl4-induced toxicity in liver, lung, brain, and spleen. This was indicated by a significant improvement in the oxidative stress and necroinflammation in these tissues.
Organ/body weight ratio and liver function markers
The organ/b.w ratio results showed a non-significant difference between all the studied groups for the liver and brain tissues. However, a significant (p < 0.05) elevation in these ratios was observed in the lung and spleen tissues after CCl4 administration only, by 276.431 and 86.067%, respectively (Fig. 1C).
The serum analysis for the liver function markers (Fig. 1D) showed significant (p < 0.05) decline in the ALT activity (75.146%) and albumin level (36.707%) in the rats that were injected with CCl4 compared to the control rats. The remaining studied serum markers (AST and total proteins) revealed slight changes (7.323% and 3.287%, respectively) than the control. Concerning rats in the CCl4-ASE group, the ALT activity and albumin level were significantly (p < 0.05) increased by 604.471% and 21.081%, respectively, but there was no change in the AST activity (21.254%) and total protein level (6.134%) compared to those in the CCl4 group. The V group displayed a non-significant difference in the ALT activity (13.255%), AST activity (2.834%), albumin level (3.584%), and total protein level (7.658%), relative to the control. Similarly, the serum of rats that administered ASE alone showed slight differences in the AST activity (5.883%), albumin level (12.640%), and total protein level (9.550%) relative to control. In contrast, the activity of ALT was significantly (p < 0.05) elevated (195.865%) in the rats of this group compared to that in C group.
Improving the CCl4-induced hepatic redox state disturbance by ASE
Figure 2A and B shows that CCl4 induced hepatic oxidative stress, which was explained by a significant (p < 0.05) elevation of ROS (256.163%), NO (369.80%), and lipid peroxidation (904.382%) levels as well as myeloperoxidase (MPO) activity (163.715 %) relative to the C group. This is connected with significant (p < 0.05) decrease in the TAC (55.495%), enzymatic (superoxide dismutase "SOD" (46.893%) and glutathione peroxidase "GPX" (81.913%)) and non-enzymatic (reduced glutathione "GSH" (54.123%)) antioxidants relative to the C group (Fig. 2A, C, D). While the administration of ASE after CCl4 injection (CCl4-ASE group) significantly (p < 0.05) reduced the levels of ROS, NO, TBARS, and the activity of MPO by 48.057%, 59.599%, 68.208%, and 26.847%, respectively, relative to the CCl4 group (Fig. 2A, B, D). Moreover, ASE significantly (p < 0.05) augmented the levels of hepatic TAC (103.374%) and GSH (19.864%), and the activities of GPX (346.491%) and SOD (92.01%) compared to those in the CCl4 group (Fig. 2C, D).
Regarding rats that were injected with olive oil alone (V group), they showed non-significant changes in all the studied oxidative stress parameters. The changes in ROS, TAC, TBARS, NO, GPX, GSH, SOD and MPO were 7.520%, 21.979%, 21.823%, 34.118%, 3.536%, 3.339%, 12.207%, and 4.219%, respectively, compared to those in the control rats. On the other hand, the rats that were administered ASE alone for 10 days (ASE group) showed a non-significant change in the levels of ROS, TAC, TBARS, and NO and the activity of SOD and MPO than the control (7.779%, 6.143%, 5.492%, 1.859%, 3.550%, and 5.953%, respectively). While the activity of GPX and the level of GSH were significantly (p < 0.05) elevated by 12.783% and 20.611%, respectively when compared to those in the C group (Fig. 2C).
Improving the CCl4-induced brain redox state disturbance by ASE
Figure 3A and B shows the toxic effect of CCl4 on brain tissue through the induction of oxidative stress, which is indicated by the significant (p < 0.05) rise in the levels of intracellular ROS (185.182 %), NO (140.579%), and TBARS (480.468%) as compared to the C group. Otherwise, there was a non-significant (36.179%) difference in the MPO activity in the brain tissue of rats injected with CCl4 and the control ones (Fig. 3D). Moreover, the cellular redox state (TAC), the activity of GPX and SOD, and the level of GSH were extremely reduced by 63.778%, 42.000%, 37.463 %, and 58.677%, respectively related to the C group (Fig. 3A, C, D). Treatment of CCl4-injected rats with ASE (CCl4-ASE group) significantly incremented the cellular redox state of the brain tissue. This was shown by a significant (p < 0.05) decrease in the levels of accumulated intracellular ROS (28.951%), TBARS (61.184%), and NO (46.038%), respectively relative to that of CCl4 group (Fig. 3A, B). In contrast, the data analysis found a significant increase (p < 0.05) in the TAC (48.006%) and GSH (59.799%) levels and the GPX (51.519%) and SOD (72.019%) activities after ASE treatment compared to those in the CCl4 group (Fig. 3A, C, D). While a non-significant change (41.511%) was observed in the activity of MPO in this group compared to those in the CCl4 group (Fig. 3D).
The results also detected a significant (p < 0.05) elevation in the ROS, TBARS, and NO levels in the brain of rats injected with olive oil only (V group) compared to those in the control group (Fig. 3B). However, the antioxidant indices (Fig. 3A, C, D) in the brain of these rats, such as the TAC (44.444%), GSH (29.822%), GPX (17.578%), and SOD (30.741%) were significantly (p < 0.05) diminished relative to control. But the MPO activity decreased insignificantly (17.903%) in the brain tissue of these rats, relative to the control group (Fig. 3D). On the other hand, administration of ASE alone (ASE group) insignificantly affected the levels of ROS (11.584%), TAC (0.500%), TBARS (11.519%), NO (0%), and GSH (8.239%) or the activities of GPX (3.209%), SOD (7.587%), and MPO (30.220%) compared to those in the control group.
Improving the CCl4-induced lung redox state disturbance by ASE
Figure 4A, B shows that CCl4 caused harm to the lung redox state with a massive rise in the levels of ROS (591.297%) and NO (483.908%), compared to those in the C group, which led to an incredible formation of TBARS (361.120%). Also, compared to that of the control group, there was a significant increase in the MPO activity by 57.318%. Conversely, the lung enzymatic (GPX and SOD) and non-enzymatic (GSH) antioxidants enormously reduced by 69.426%, 27.635%, and 82.387%, respectively, compared to those in the C group (Fig. 4C, D). Consequently, TAC of lung tissue significantly dropped in the CCl4-injected rats by 65.780%, related to the control group (Fig. 4A). The treatment with ASE after CCl4-injection (CCl4-ASE group) improved the redox state in lung tissue extremely. This occurred due to the significant (p < 0.05) decrease in the studied oxidative stress parameters, ROS, NO, TBARS, and MPO levels, by 43.448%, 50.098%, 72.211%, 20.594%, respectively, compared to those in the CCl4 group (Fig. 4A, B, D). Besides, ASE significantly (p < 0.05) enhanced the lung antioxidant system (SOD, GPX, and GSH) by 48.505%, 160.157%, and 386.431%, relative to the CCl4 group (Fig. 5C, D). These results concomitantly led to an increase in the lung tissue TAC (64.683%) related to that in the CCl4 group (Fig. 5A).
On the other hand, the lung tissue of rats in the vehicle (V) group showed an alteration in the redox state parameters. Hence ROS, NO, and TBARS significantly (p < 0.05) increased by 43.619%, 158.818%, and 24.490%, compared to the C group. Also, the antioxidant parameters, including GPX (22.390%), GSH (24.611%), and SOD (3.469%) depleted significantly (p < 0.05) and as a result, the TAC (27.389%) decreased compared to the control group (Fig. 4A, C, D), while the activity of MPO in the lung of the rats in this group insignificantly increased (0.456%), compared to that in the C group. Nevertheless, the administration of ASE alone for 10 days (ASE group) displayed non-significant changes in the studied oxidative stress parameters in lung tissue compared to the C group. These parameters include ROS (12.146 %), TBARS (2.306%), NO (10.344%), MPO (11.409%), GPX (18.502 %), GSH (5.813%), SOD (10.135%), and TAC (4.137%).
Improving the CCl4-induced spleen redox state disturbance by ASE
The results showed that CCl4 injection can also influence spleen oxidative stress and cause a massive elevation in ROS (292.700%) and NO (182.978%) levels, which leads to an excessive generation of lipid peroxide (TBARS, 395.516%), compared to that of the C group (Fig. 5A, B). Likewise, there was a significant (p < 0.05) elevation in MPO activity (165.852%) compared to the control group (Fig. 5D). In contrast, there was a significant (p < 0.05) falling in the spleen antioxidant content, GPX (77.092%), GSH (75.735%), and SOD (50.388%), related to the control group (Fig. 5C, D). Therefore, the TAC (63.063%) of spleen tissue significantly (p < 0.05) diminished in the CCl4-injected rats, compared to the C group (Fig. 5A). Otherwise, the treatment of the CCl4-injected rats with ASE (CCl4-ASE group) enormously decreased the oxidative stress examined parameters, including ROS, NO, TBARS, and MPO level by 37.638%, 50.024%, 68.477%, 38.071%, sequentially, compared to those of the CCl4 group (Fig. 5A, B, D). Moreover, ASE enhanced the spleen antioxidant status by a significant (p < 0.05) elevation in the activity of GPX and SOD, and the level of GSH by 323.942%, 124.237%, and 126.792%, compared to those in the CCl4 group (Fig. 5C, D). In addition, the TAC of the spleen tissue was augmented by 195.244% more than the CCl4 group (Fig. 5A).
On the other hand, the spleen of rats that were injected with olive oil only for 3 weeks (V group) showed a slight increase in the levels of ROS (10.537%), TAC (0.677%), and TBARS (16.592%), compared to the C group (Fig. 5A, B). Similarly, there was a slight change in the activities of SOD (5.972%) and MPO (36.980%) (Fig. 5D). However, the level of NO significantly (p < 0.05) increased by 36.504% and in contrast, the activity of GPX and the level of GSH significantly (p < 0.05) reduced in the spleen of rats in this group by 15.281% and 25.714%, respectively, relative to the control rats (Fig. 5B, C). Further, the administration of ASE alone for 10 days (ASE group) showed a non-significant difference in the levels of splenic ROS (0.692%), TBARS (0.605%), NO (0.426%), and GSH (0.186%), compared to the C group. Likewise, the activities of MPO (5.071%), GPX (2.398%), and SOD (7.924%) changed slightly. Nevertheless, the level of TAC (64.865%) significantly (p < 0.05) increased in the spleen tissue after ASE intake, compared to that in the C group.
The alleviating effect of ASE on the CCl4-induced systemic necroinflammation
Figure 6 demonstrates the toxic effect of CCl4 on the studied organs by upregulating the gene expression of some pro-inflammatory and pro-fibrotic cytokines. Hence, the fold expression of the nuclear factor-kappa (NF-κ)B, inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, and tumor necrosis factor (TNF)-α, was highly upregulated after CCl4 injection, compared to the control group. These elevations were observed in liver (2691.194%, 3110.867%, 2400.977%, and 847.982%, respectively), brain (1479.924%, 1322.286%, 355.513%, and 71.140%, respectively), lung (478.041%, 455.108%, 1066.674%, and 1101.253%, respectively), and spleen (907.976%, 737.934%, 449.203%, and 52.784%, respectively). Furthermore, the fold expression of the hepatic pro-fibrotic cytokines (collagen type I alpha one chain "COL1A1", transforming growth factor-β1 "TGF-β1") was massively increased after CCl4 injection by 3082.635% and 2138.017%, respectively, compared to those in the C group (Fig. 6A). The results also detected a significant (p < 0.05) elevation in the fold expression of the interleukin (IL)-1β (957.250%) and IL-8 (557.650%) in the lung tissue of rats in the CCl4 group, compared to those in the C group (Fig. 6C).
As shown in the graphs in Fig. 6, the treatment with ASE (ASE-CCl4 group) significantly (p < 0.05) reduced the fold expression of the pro-inflammatory cytokines (NF-κB, iNOS, COX-2, and TNF-α) compared to the CCl4 group. The percentages of this depletion in the liver and brain tissues were 68.969%, 45.839%, 83.713%, and 89.234%, respectively, and 43.415%, 21.889%, 81.595%, and 37.826%, respectively. Moreover, these percentages in the lung and spleen tissues were 56.183%, 91.091%, 47.988%, and 56.609%, respectively, and 41.020%, 19.242%, 6.393%, and 35.778%, respectively. Also, ASE was capable of depleting the fold expression of IL-1β (36.460%) and IL-8 (71.668%) in lung tissue, as well as COL1A1 (12.500%) and TGF-β1 (59.812%) in liver tissue, compared to those in the CCl4 group.
The present study reported that the administration of olive oil only (V group) did not greatly influence the fold expression of the pro-inflammatory and profibrotic cytokines in the liver compared to the those in the control group (Fig. 6A). Hence, the percentage change of these mediators, including NF-κB, iNOS, COX-2, TNF-α, COL1A1, and TGF-β1, compared to those in the control group was 7.250%, 15.535%, 0.686%, 8.699%, 7.412, and 15.794%, respectively. Similarly, in the brain tissue, there was a small change in the fold expression of the studied inflammatory mediators (9.327%, 16.204%, and 10.658%, respectively), except for the COX-2, which showed a significant upregulation in its fold expression by 79.0641%, compared to that in the C group (Fig. 6B). While in the lung, the fold expression of the pro-inflammatory cytokines, comprising of NF-κB, iNOS, COX-2, TNF-α, IL-1β, and IL-8 were significantly (p < 0.05) upregulated compared to those in the C group (Fig. 6C). The percentage change for these mediators were 290.183%, 229.548%, 286.581%, 48.410%, 234.688%, and 117.364%, respectively. Regarding the spleen tissue, there was a significant (p < 0.05) elevation in the fold expression of some pro-inflammatory mediators (NF-κB "177.005%", iNOS "68.012%"), and no changes in the others (COX-2 "71.528%", TNF-α "6.648 %") after the injection with the olive oil, compared to those in the C group (Fig. 6D).
Further, the intake of ASE alone (ASE group) demonstrated a non-significant change in the fold expression of NF-κB, iNOS, COX-2, and TNF-α in the liver (6.735%, 98.537%, 6.673%, and 20.418%, respectively) and brain (99.846%, 94.732%, 4.284%, 1.494%, respectively) as shown in Fig. 6A, B. The same results were obtained with lung (7.488%, 2.495%, 7.346%, and 4.403%, respectively) and spleen (2.799%, 95.119%, 1.866%, and 0.578%, respectively) tissues (Fig. 6C, D). Besides, the fold expression of COL1A1 (9.421%) and TGF-β1 (2.564%) in the liver tissue (Fig. 6A) and IL-1β (1.072%) and IL-8 (1.386%) in the lung tissue (Fig. 6C) changed slightly compared to those in the C group.
Comparison of the ASE therapeutic efficiency in the four studied organs
Supplementary Fig. 1 represents the heatmap plot, which clusters the oxidative stress and necroinflammation tested parameters that were observed after the treatment with ASE (CCl4-ASE) in the different studied organs. The color in the heatmap elucidates the quantity (% increase relative to CCl4 group) of these different studied parameters, the higher the quantity, the darker the color. Figure (1 A) showed two clusters, one for the liver and spleen, and the other for the lung and brain. This figure illustrates the high capability of ASE in elevating the level of TAC and the activity of GPX and SOD in the liver and spleen, more than the lung and brain. However, it increased the GSH level in the lung more than in the other organs. While the heatmap in Supplementary Fig. 1 (B) demonstrates two clusters, the liver with the lung and the brain with the spleen. The figure shows the ability of ASE to decrease the levels of ROS, NO, TBARS, NF-κB, iNOS, and TNF-α, and the activity of MPO in liver and lung more than the brain and the spleen. Therefore, these heatmaps revealed that the liver was the most influenced tissue, and the therapeutic values of ASE and the brain were the lowest.
Histopathological results
The microscopic examination of the processed formalin-fixed sections of the studied organs revealed the systemic toxicity of CCl4 and the ameliorating impact of ASE on the different tested organs (Fig. 7). The control sections of the liver revealed the hepatic central vein (CV) with normal lobular architecture and radiating liver cell cords. CCl4 injection showed severe hepatotoxicity, which indicated severe steatohepatitis with fibrous bands. In addition, the features of necroinflammation such as congested blood vessels with infiltration of mononuclear leucocytes and necrotic and binucleated hepatocytes were observed. The treatment with ASE (CCl4-ASE) restored the normal morphology of the liver with only a mild dilation of the CV. Injection with olive oil only (V group) showed severe dilation of the CV with infiltration of mononuclear leucocytes, as well as mild sinusoidal cells activation. However, no pathological changes were detected in the liver of rats that were administered ASE only for 10 days (ASE group).
Regarding the brain, the control tissues showed normal architecture with normal glial cells and neurons. This normal morphology was changed after CCl4 injection to severe damage with severe degeneration of neurons that was characterized by the appearance of pyknotic nuclei and vacuoles in the neuronal cells. Administration of ASE restored the architecture of the brain and relieved the CCl4 toxicity. Injection with olive oil to rats (V group) caused mild degeneration of the neurons, which appeared with pyknotic nuclei and vacuoles in addition to the accumulation of the inflammatory cells in their vicinity. All these features reflected the induction of necroinflammation in the brain tissue of rats in the V group, while the oral administration of ASE alone (ASE group) didn’t affect the normal morphology of the brain.
The lung tissue in control rats had the normal appearance of the alveolar sacs and alveolar walls. Massive disruption was observed in its morphology after injection with CCl4, which is characterized by inflammatory cells influx with alveolar wall thickness and alveolar epithelium damage. Great amelioration in the lung morphology was observed following the administration of ASE (CCl4-ASE) compared to those in the CCl4 group. Hence, the lung tissue seemed normal with only mild thickness in the alveolar septae. In contrast, thickness in the alveolar septae with infiltration of the inflammatory cells and narrowing of the alveolar air spaces have appeared in the lung tissue sections of the animals in the V group, while no abnormal features were observed in the morphology of lung tissue in the rats of the ASE group.
Regarding the spleen tissue, it appears normal with well-defined red and white pulp regions in the control rats. Severe disturbance in these regions with extreme infiltration of inflammatory cells was detected following the injection with CCl4. This damage was relieved after the intake of ASE (CCl4-ASE), except for the slight influx of inflammatory cells. Moderate disorganized white pulp compartment with unclear regions and mild recruitment of inflammatory cells were observed in the spleen tissues of the V group. However, the spleen tissues of animals in the ASE group showed normal architecture and well distinct white and red pulp compartments like the control group.